People · Operator
Named in public records as an officer, director or promoter · active 2009–2014 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alere Inc. | — | Other Health Care | Series D+ | $500.0M | $9.2B | 2009 |
| Immunetics, Inc. | — | Biotechnology | Pre-Seed | $1.5M | $46.1M | 2014 |
John Yonkin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Yonkin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| RON ZWANZIGER | 2 | 6 |
| ANDREW LEVIN | 1 | 17 |
| David Scott | 1 | 12 |
| John Levy | 1 | 10 |
| Brian Mitchell | 1 | 4 |
| John Peterson | 1 | 4 |
| John Quelch | 1 | 4 |
| David Walton | 1 | 3 |
| RON GERATY | 1 | 3 |
| PHILIP BUCHANAN | 1 | 3 |
| RICHARD GIBBS | 1 | 2 |
| Jerry McAleer | 1 | 2 |
| Peter Scheu | 1 | 2 |
| STEPHEN CHUBB | 1 | 2 |
| Tom Underwood | 1 | 2 |
| RICHARD PINKOWITZ | 1 | 1 |
| HOURY YOUSSOUFIAN | 1 | 1 |
| Paul Hempel | 1 | 1 |
| David Teitel | 1 | 1 |
| LOIS SILVERMAN | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.